Track 2: Protein Folding
Protein folding is the quick and repeatable physical process by which a protein chain develops its native 3-dimensional structure, a shape that is typically biologically useful. Since a few years ago, scientists have continued to investigate the myriad mechanisms, forces at work, and processes involved in protein folding.
Related Conference of Track 2: Protein Folding
October 30-31, 2025
20th World Congress on Biomarkers, Cancer Therapy & Clinical Research
Rome, Italy
June 29-30, 2026
41st International Conference on Next-Gen Biotechnology and Applications
Aix-en-Provence, France
Track 2: Protein Folding Conference Speakers
Recommended Sessions
- Genomics & Structural Genomics
- Track 10 : Pharmacogenomics & Pharmacoproteomics
- TRACK 1: Protein Engineering
- Track 2: Protein Folding
- Track 4 : Enzyme Engineering
- Track 5: Protein Engineered Biomaterials
- Track 6: Structure and Function of Proteins
- Track 8: Protein Engineered Biomaterials
- Track 9: Proteomics in Plant & Animal
- TRACK3: Genetic Engineering
Related Journals
Are you interested in
- Advancements in Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Advancements in Biosimilar Development Technologies - Biosimilars 2026 (France)
- Advances in Genomic Biotechnology - Biotechnology 2025 (Spain)
- Agriculture Biotechnology - Euro Biotechnology 2026 (Italy)
- Analytical Challenges in Personalized Medicine - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in Agriculture - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in the Energy Sector - ANALYTICA ACTA 2026 (France)
- Analytical Techniques for Biotechnology - ANALYTICA ACTA 2026 (France)
- Analytical Techniques in Material Science - ANALYTICA ACTA 2026 (France)
- Animal Biotechnology - Euro Biotechnology 2026 (Italy)
- Artificial Intelligence and Digital Tools in Biotherapeutics - Biosimilars 2026 (France)
- Automation in Bioanalytical Laboratories - ANALYTICA ACTA 2026 (France)
- Bio-Safety and Bioethics - Euro Biotechnology 2026 (Italy)
- Bioanalytical Method Development and Validation - ANALYTICA ACTA 2026 (France)
- Biobetters: The Next Generation of Biologics - Biosimilars 2026 (France)
- Bioinformatics & Computational Biology - Euro Biotechnology 2026 (Italy)
- Bioinformatics and Computational Approaches - ANALYTICA ACTA 2026 (France)
- Biomaterials - Euro Biotechnology 2026 (Italy)
- Biomedical Biotechnology - Biotechnology 2025 (Spain)
- Biomedical Engineering & Applications - Euro Biotechnology 2026 (Italy)
- Biopharmaceuticals and Biologics - ANALYTICA ACTA 2026 (France)
- Biopharmaceuticals and Biosimilars - Biotechnology 2025 (Spain)
- Bioprocess and Fermentation Technology - Euro Biotechnology 2026 (Italy)
- Bioremediation and Biodegradation - Euro Biotechnology 2026 (Italy)
- Biosimilar Market Access and Reimbursement Policies - Biosimilars 2026 (France)
- Biosimilars in Oncology and Autoimmune Diseases - Biosimilars 2026 (France)
- Biosimilars in Rare and Orphan Diseases - Biosimilars 2026 (France)
- Biotechnology - Euro Biotechnology 2026 (Italy)
- Biotechnology and Global Health - Biotechnology 2025 (Spain)
- Biotechnology Applications - Euro Biotechnology 2026 (Italy)
- Biotechnology in Agriculture - Biotechnology 2025 (Spain)
- Biotechnology in Dentistry - Euro Biotechnology 2026 (Italy)
- Chemical Analysis and Sensing - ANALYTICA ACTA 2026 (France)
- Clinical and Forensic Analysis - ANALYTICA ACTA 2026 (France)
- Clinical Trials & Comparability Studies for Biosimilars - Biosimilars 2026 (France)
- Collaborative Models in Biosimilar Development - Biosimilars 2026 (France)
- Computational and Systems Biology - Biotechnology 2025 (Spain)
- Cost-Effectiveness and Health Economics of Biosimilars - Biosimilars 2026 (France)
- Data Integrity and Compliance in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Emerging Contaminants and Analytical Challenges - ANALYTICA ACTA 2026 (France)
- Emerging Trends in Analytical and Bioanalytical Techniques - ANALYTICA ACTA 2026 (France)
- Environmental Analysis - ANALYTICA ACTA 2026 (France)
- Environmental Biotechnology - Biotechnology 2025 (Spain)
- Environmental Biotechnology - Euro Biotechnology 2026 (Italy)
- Enzyme and Protein Engineering - Euro Biotechnology 2026 (Italy)
- Evolving Trends and Innovations in Biosimilar Development and Access - Biosimilars 2026 (France)
- Food and Beverage Analysis - ANALYTICA ACTA 2026 (France)
- Food and Feed Biotechnology - Euro Biotechnology 2026 (Italy)
- Formulation and Delivery Systems for Biologics - Biosimilars 2026 (France)
- Future Biotherapeutics: Cell and Gene Therapies - Biosimilars 2026 (France)
- Future of Monoclonal Antibodies and Fusion Proteins - Biosimilars 2026 (France)
- Future Trends in Biotechnology - Biotechnology 2025 (Spain)
- Genetics and Molecular biotechnology - Euro Biotechnology 2026 (Italy)
- Genomics and Molecular Biology Analysis - ANALYTICA ACTA 2026 (France)
- Global Trends and Challenges in Biosimilar Adoption - Biosimilars 2026 (France)
- High-Resolution Techniques - ANALYTICA ACTA 2026 (France)
- Imaging Techniques and Microscopy - ANALYTICA ACTA 2026 (France)
- Immunogenicity Assessment and Risk Management - Biosimilars 2026 (France)
- Industrial and Manufacturing Biotechnology - Euro Biotechnology 2026 (Italy)
- Industrial Biotechnology - Biotechnology 2025 (Spain)
- Industrial Scale-Up and Bioprocessing - Biotechnology 2025 (Spain)
- Instrumentation and Automation in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Interchangeability and Substitution Policies - Biosimilars 2026 (France)
- Manufacturing and Quality Control of Biosimilars - Biosimilars 2026 (France)
- Marine Biotechnology - Biotechnology 2025 (Spain)
- Marine Biotechnology - Euro Biotechnology 2026 (Italy)
- Medical Biotechnology - Euro Biotechnology 2026 (Italy)
- Metabolomics and Proteomics - ANALYTICA ACTA 2026 (France)
- Microbial Biotechnology - Euro Biotechnology 2026 (Italy)
- Microbial Biotechnology - Biotechnology 2025 (Spain)
- Nano Biotechnology - Euro Biotechnology 2026 (Italy)
- Nanomaterials and Nanotechnology in Analysis - ANALYTICA ACTA 2026 (France)
- Oncolytic Biotechnology - Euro Biotechnology 2026 (Italy)
- Patient and Physician Perspectives on Biosimilar Use - Biosimilars 2026 (France)
- Pharmaceutical Analysis - ANALYTICA ACTA 2026 (France)
- Pharmaceutical Biotechnology and Drug Design - Euro Biotechnology 2026 (Italy)
- Pharmacovigilance and Post-Marketing Surveillance - Biosimilars 2026 (France)
- Plant and Forest Biotechnology - Euro Biotechnology 2026 (Italy)
- Quality by Design (QbD) in Analytical Method Development - ANALYTICA ACTA 2026 (France)
- Regenerative Medicine and Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Regulatory Pathways and Global Harmonization - Biosimilars 2026 (France)
- Spectroscopic Techniques - ANALYTICA ACTA 2026 (France)
- Stem Cell and Regenerative Medicine - Biotechnology 2025 (Spain)
- Stem Cell Biotechnology and Regenerative Medicine - Euro Biotechnology 2026 (Italy)
- Surface and Interface Analysis - ANALYTICA ACTA 2026 (France)
- Synthetic Biology and Bioengineering - Biotechnology 2025 (Spain)
- Vaccine Development and Immunotherapy - Biotechnology 2025 (Spain)
- Workshops and Hands-On Training - ANALYTICA ACTA 2026 (France)